HealthEquity stock’s recent year-to-date underperformance is partly due to its disclosure of fraud against some of its HSA customers and near-term investor concerns about recent management changes.

Fintel reports that on March 25, 2025, Raymond James upgraded their outlook for HealthEquity (NasdaqGS ... VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,744K shares ...

KeyBanc Capital Markets adjusted its valuation of HealthEquity, Inc. (NASDAQ:HQY), reducing the price target to $110... ByInvesting.com• Mar 24, 2025 Citi maintains Neutral on Alfa Laval stock ...

Raymond James sees the underlying fundamentals and strategic positioning of HealthEquity as strong, and believes the stock’s current levels offer an attractive opportunity for long-term investors, ...

On Tuesday, HealthEquity, Inc. (NASDAQ: HQY) received an upgrade in its stock rating from Raymond (NSE:RYMD) James, moving from... On Tuesday, Mizuho Securities adjusted its stance on EOG Resources ...

On Monday, KeyBanc Capital Markets adjusted its valuation of HealthEquity, Inc. (NASDAQ:HQY), reducing the price target to $110... ByInvesting.com• Mar 24, 2025 Citi maintains Sell rating on Ferrari ...

HQY stock is down more than 13% YTD amid cyber threats and rising costs, but strong HSA fundamentals remain. Is it time to hold or fold? Let's break it down.

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Mizuho started ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $112.5, ...